CSWC Stock Analysis: Capital Southwest | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 1.577m USD | 12M Return: 24.9% | US1405011073 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 9.75M
EPS Trend: -93.0%
Qual. Beats: 0
Rev. Trend: 96.2%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Capital Southwest Corporation (CSWC) is a Business Development Company (BDC) that specializes in providing credit and private equity/venture capital investments to lower middle market companies. BDCs are regulated investment vehicles under the Investment Company Act of 1940, typically required to distribute the majority of their taxable income to shareholders, and they serve as a key source of financing for small and mid-sized private businesses that lack access to public capital markets.
The firm invests through a range of structures, including unitranche debt, subordinated debt, senior debt, first and second lien debt, and preferred and common equity. It makes non-control investments only, with equity co-investments capped at approximately 20% of the total check size. CSWC explicitly avoids startups, publicly traded companies, real estate developments, project finance, oil and gas exploration, troubled companies, and turnaround situations.
While industry-agnostic, CSWC favors sectors such as industrial manufacturing and services, value-added distribution, healthcare products and services, business services, specialty chemicals, food and beverage, and tech-enabled services including SaaS models. Within energy services and products, the firm invests across upstream, midstream, and downstream segments (excluding exploration and production), with emphasis on differentiated products, equipment rental, consumables, and drilling and completion chemicals. In industrial technologies, focus areas include automation and process controls, handling and packaging equipment, industrial filtration, measurement and monitoring tools, professional tools, and sensors and instrumentation.
- Fed rate hikes boost floating rate investment income
- Credit quality holds as non-accrual rates stay low
- Capital deployment accelerates in lower middle market
| Net Income: 106.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.17 > 0.02 and ΔFCF/TA -3.59 > 1.0 |
| NWC/Revenue: -51.71% < 20% (prev -53.64%; Δ 1.94% < -1%) |
| CFO/TA -0.17 > 3% & CFO -426.7m > Net Income 106.5m |
| Net Debt (1.34b) to EBITDA (172.2m): 7.76 < 3 |
| Current Ratio: 0.43 > 1.5 & < 3 |
| Outstanding Shares: last quarter (73.0m) vs 12m ago 12.66% < -2% |
| Gross Margin: 94.38% > 18% (prev 68.36%; Δ 26.03% > 0.5%) |
| Asset Turnover: 10.92% > 50% (prev 9.57%; Δ 1.35% > 0%) |
| Interest Coverage Ratio: 2.21 > 6 (EBIT TTM 165.0m / Interest Expense TTM 74.8m) |
| A: -0.05 (Total Current Assets 97.9m - Total Current Liabilities 226.3m) / Total Assets 2.52b |
| B: -0.05 (Retained Earnings -113.9m / Total Assets 2.52b) |
| C: 0.07 (EBIT TTM 165.0m / Avg Total Assets 2.27b) |
| D: 0.78 (Book Value of Equity 1.11b / Total Liabilities 1.42b) |
| Altman-Z'' = 0.83 = B |
As of November 19, 2026, the stock is trading at USD 22.97 with a total of 334,128 shares traded. Over the past week, the price has changed by -2.32%, over one month by +2.84%, over three months by -4.02% and over the past year by +24.88%.
Current recommended Stop Loss: 22.30 (which is 2.9% or 1.6 ATR below the current price).
Capital Southwest has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CSWC.
- StrongBuy: 3
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 25.1 | 9.2% |
P/E Trailing = 13.8655
P/E Forward = 10.7759
P/S = 6.3722
P/B = 1.4186
P/EG = 12.5385
Revenue TTM = 248.3m USD
EBIT TTM = 165.0m USD
EBITDA TTM = 172.2m USD
Long Term Debt = 1.16b USD (estimated: total debt 1.38b - short term 225.3m)
Short Term Debt = 225.3m USD (from shortTermDebt, last quarter)
Debt = 1.38b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.34b USD (calculated: Debt 1.38b - CCE 48.0m)
Enterprise Value = 2.91b USD (1.58b + Debt 1.38b - CCE 48.0m)
Interest Coverage Ratio = 2.21 (Ebit TTM 165.0m / Interest Expense TTM 74.8m)
EV/FCF = -6.83x (Enterprise Value 2.91b / FCF TTM -426.8m)
FCF Yield = -14.65% (FCF TTM -426.8m / Enterprise Value 2.91b)
FCF Margin = -171.9% (FCF TTM -426.8m / Revenue TTM 248.3m)
Net Margin = 42.91% (Net Income TTM 106.5m / Revenue TTM 248.3m)
Gross Margin = 94.38% ((Revenue TTM 248.3m - Cost of Revenue TTM 13.9m) / Revenue TTM)
Gross Margin QoQ = 94.83% (prev 94.15%)
Tobins Q-Ratio = 1.15 (Enterprise Value 2.91b / Total Assets 2.52b)
Interest Expense / Debt = 5.40% (Interest Expense 74.8m / Debt 1.38b)
Taxrate = 1.61% (1.74m / 108.3m)
NOPAT = 162.3m (EBIT 165.0m * (1 - 1.61%))
Current Ratio = 0.43 (Total Current Assets 97.9m / Total Current Liabilities 226.3m)
Debt / Equity = 1.25 (Debt 1.38b / totalStockholderEquity, last quarter 1.11b)
Debt / EBITDA = 7.76 (Net Debt 1.34b / EBITDA 172.2m)
Debt / FCF = -3.13 (negative FCF - burning cash) (Net Debt 1.34b / FCF TTM -426.8m)
Total Stockholder Equity = 1.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.69% (Net Income 106.5m / Total Assets 2.52b)
RoE = 10.22% (Net Income TTM 106.5m / Total Stockholder Equity 1.04b)
RoCE = 7.49% (EBIT 165.0m / Capital Employed (Equity 1.04b + L.T.Debt 1.16b))
RoIC = 5.98% (NOPAT 162.3m / Invested Capital 2.72b)
WACC = 6.64% (E(1.58b)/V(2.96b) * Re(7.80%) + D(1.38b)/V(2.96b) * Rd(5.40%) * (1-Tc(0.02)))
Discount Rate = 7.80% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 94.69 | Cagr: 23.21%
[DCF] Fair Price = unknown (Cash Flow -426.8m)
EPS Correlation: -93.01 | EPS CAGR: -6.10% | SUE: 0.0 | # QB: 0
Revenue Correlation: 96.17 | Revenue CAGR: 21.14% | SUE: 0.35 | # QB: 0
EPS current Quarter (2026-12-31): EPS=0.57 | Chg30d=+0.60% | Revisions=+12% | Analysts=6
EPS current Year (2027-03-31): EPS=2.27 | Chg30d=+1.50% | Revisions=+25% | GrowthEPS=-4.1% | GrowthRev=+18.2%
EPS next Year (2028-03-31): EPS=2.37 | Chg30d=+1.65% | Revisions=+25% | GrowthEPS=+4.4% | GrowthRev=+18.8%
[Analyst] Revisions Ratio: +30% (up=5, down=2)